Sure is about perspective... and it's all relative

Sure is about perspective... and it's all relative.

I also am new to CYDY (months researching and dove in late March -last day it was under $1 and bought as high as $3.25)... I do understand how longs feel holding for years, as I had done that with other companies/stocks (unfortunately for naught). CytoDyn longs though are very lucky because they've been in a real company with a real product... a drug that is worthy of the years of waiting and having patience. Lucky because the unfortunate and tragic Covid-19 pandemic is giving this company/drug a big boost and possibly expediting it for cancers/HIV. Glad to see the company taking advantage while saving lives!

My husband... and many I might add... cannot understand why the rest of the media, administration and the public have yet to discover or publicly speak of or hear about Leronlimab. While he understands it's been in development for cancer and HIV, he feels with the Covid-19 pandemic the only focus should be on what's immediately happening and to save the hundreds-of-thousands of lives lost and millions ill.... right now.

To that end, Dr. Patterson should be speaking in simple terms about the medical/health benefits of using Leronlimab and an articulate public relations person who understands securities (stocks and how they play out) should be with the CEO speaking about what the company is doing.

My hope is that will be what we see ahead... when the FDA comes around to giving the green light for Leronlimab for Covid-19 patients...